Top 5 Health Care Stocks That May Fall Off A Cliff This Month
Portfolio Pulse from Lisa Levin
Five health care stocks, Werewolf Therapeutics, Inc. (HOWL), Dermata Therapeutics, Inc. (DRMA), CVRx, Inc. (CVRX), Owens & Minor, Inc. (OMI), and Aura Biosciences, Inc. (AURA), are considered overbought according to their RSI values, indicating they may be overvalued and could experience a price drop in the short term.
November 06, 2023 | 1:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aura Biosciences' stock is overbought with an RSI of 80.72, indicating potential for a price drop.
The RSI value of 80.72 is significantly above the overbought threshold of 70, suggesting that the stock is currently overvalued and may experience a price correction in the near future.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
CVRx's stock is overbought with an RSI of 81.68, indicating potential for a price drop.
The RSI value of 81.68 is significantly above the overbought threshold of 70, suggesting that the stock is currently overvalued and may experience a price correction in the near future.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Dermata Therapeutics' stock is overbought with an RSI of 71.80, indicating potential for a price drop.
The RSI value of 71.80 is slightly above the overbought threshold of 70, suggesting that the stock is currently overvalued and may experience a price correction in the near future.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Werewolf Therapeutics' stock is overbought with an RSI of 77.40, indicating potential for a price drop.
The RSI value of 77.40 is well above the overbought threshold of 70, suggesting that the stock is currently overvalued and may experience a price correction in the near future.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Owens & Minor's stock is overbought with an RSI of 84.50, indicating potential for a price drop.
The RSI value of 84.50 is significantly above the overbought threshold of 70, suggesting that the stock is currently overvalued and may experience a price correction in the near future.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100